RBC Capital Starts Salix Pharmaceuticals (SLXP) at Outperform
Tweet
Share
E-mailGet Alerts SLXP Hot Sheet
Price: $172.81 --0%
Rating Summary:
7 Buy, 14 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 5 | Down: 17 | New: 22
Rating Summary:
7 Buy, 14 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 5 | Down: 17 | New: 22
Join SI Premium – FREE
RBC Capital initiates coverage on Salix Pharmaceuticals (NASDAQ: SLXP) with a Outperform. PT $53.00.
For an analyst ratings summary and ratings history on Salix Pharmaceuticals click here. For more ratings news on Salix Pharmaceuticals click here.
Shares of Salix Pharmaceuticals closed at $45.59 yesterday.
For an analyst ratings summary and ratings history on Salix Pharmaceuticals click here. For more ratings news on Salix Pharmaceuticals click here.
Shares of Salix Pharmaceuticals closed at $45.59 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Truist Securities Starts Vishay Intertechnology (VSH) at Buy
- Morgan Stanley Starts Banca Mediolanum SpA (BMED:IM) at Equalweight
- Morgan Stanley Resumes Euronext NV (ENX:FP) (EUXTF) at Overweight
Create E-mail Alert Related Categories
New CoverageRelated Entities
RBC CapitalSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
